Inflammatory cytokines in vascular dysfunction and vascular disease

Biochemical Pharmacology

Volumn 78, Issue 6, 2009, Pages 539-552

  Sprague, Alexander H ^a   Khalil, Raouf A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Aneurysm; Endothelium; Hypertension; Interleukins; Matrix metalloproteinases; Oxidative stress; Varicose veins; Vascular smooth muscle

Indexed keywords

ADALIMUMAB; AMLODIPINE; AZELNIDIPINE; BETA INTERFERON; CERTOLIZUMAB PEGOL; CHEMOKINE RECEPTOR; CYTOKINE; CYTOKINE RECEPTOR; ETANERCEPT; FASUDIL; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLIXIMAB; INTERCELLULAR ADHESION MOLECULE 1; INTERFERON RECEPTOR; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; JANUS KINASE; MACROPHAGE INFLAMMATORY PROTEIN 1; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SMAD PROTEIN; STAT PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; VASCULAR CELL ADHESION MOLECULE 1;

ABDOMINAL AORTA ANEURYSM; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR INFLAMMATION; CYTOKINE PRODUCTION; DRUG ELUTING STENT; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HYPERTENSION; IN-STENT RESTENOSIS; INFLAMMATORY CELL; NONHUMAN; OXIDATIVE STRESS; PREECLAMPSIA; PRIORITY JOURNAL; VARICOSIS; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE;

EID: 67651146363     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2009.04.029     Document Type: Note

References (100)

1. Szmitko P.E., Wang C.H., Weisel R.D., de Almeida J.R., Anderson T.J., and Verma S. New markers of inflammation and endothelial cell activation: Part I. Circulation 108 16 (2003) 1917-1923
2. Zhang C. The role of inflammatory cytokines in endothelial dysfunction. Basic Res Cardiol 103 5 (2008) 398-406
3. Hirano T. Molecular basis underlying functional pleiotropy of cytokines and growth factors. Biochem Biophys Res Commun 260 2 (1999) 303-308
4. Ozaki K., and Leonard W.J. Cytokine and cytokine receptor pleiotropy and redundancy. J Biol Chem 277 33 (2002) 29355-29358
5. Luster A.D. Chemokines - chemotactic cytokines that mediate inflammation. N Engl J Med 338 (1998) 436-445
6. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 3 1 (2003) 23-35
7. Tedgui A., and Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 86 2 (2006) 515-581
8. McNicol A., and Israels S.J. Beyond hemostasis: the role of platelets in inflammation, malignancy and infection. Cardiovasc Hematol Disord Drug Targets 8 2 (2008) 99-117
9. Grötzinger J. Molecular mechanisms of cytokine receptor activation. Biochim Biophys Acta 1592 3 (2002) 215-223
10. Uzé G., Schreiber G., Piehler J., and Pellegrini S. The receptor of the type I interferon family. Curr Top Microbiol Immunol 316 (2007) 71-95
11. Bradley J.R. TNF-mediated inflammatory disease. J Pathol 214 2 (2008) 149-160
12. Schober A. Chemokines in vascular dysfunction and remodeling. Arterioscler Thromb Vasc Biol 28 11 (2008) 1950-1959
13. Taniguchi T. Cytokine signaling through nonreceptor protein tyrosine kinases. Science 268 5208 (1995) 251-255
14. Kofler S., Nickel T., and Weis M. Role of cytokines in cardiovascular diseases: a focus on endothelial responses to inflammation. Clin Sci (Lond) 108 3 (2005) 205-213
15. Ihle J.N. The Stat family in cytokine signaling. Curr Opin Cell Biol 13 2 (2001) 211-217
16. Bond M., Chase A.J., Baker A.H., and Newby A.C. Inhibition of transcription factor NF-kappaB reduces matrix metalloproteinase-1, -3 and -9 production by vascular smooth muscle cells. Cardiovasc Res 50 3 (2001) 556-565
17. Venkatesha S., Toporsian M., Lam C., Hanai J., Mammoto T., Kim Y.M., et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2 (2006) 642-649
18. Lu Q., Harrington E.O., Jackson H., Morin N., Shannon C., and Rounds S. Transforming growth factor-beta1-induced endothelial barrier dysfunction involves Smad2-dependent p38 activation and subsequent RhoA activation. J Appl Physiol 101 2 (2006) 375-384
19. ten Dijke P., and Arthur H.M. Extracellular control of TGFbeta signalling in vascular development and disease. Nat Rev Mol Cell Biol 8 11 (2007) 857-869
20. Cohen T., Nahari D., Cerem L.W., Neufeld G., and Levi B.Z. Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem 271 (1996) 736-741
21. Ikeda U., Ikeda M., Oohara T., Kano S., and Yaginuma T. Mitogenic action of interleukin-1 alpha on vascular smooth muscle cells mediated by PDGF. Atherosclerosis 84 2-3 (1990) 183-188
22. Nomoto A., Mutoh S., Hagihara H., and Yamaguchi I. Smooth muscle cell migration induced by inflammatory cell products and its inhibition by a potent calcium antagonist, nilvadipine. Atherosclerosis 72 2-3 (1988) 213-219
23. Muzio M., Stockwell B.R., Stennicke H.R., Salvesen G.S., and Dixit V.M. An induced proximity model for caspase-8 activation. J Biol Chem 273 5 (1998) 2926-2930
24. Madge L.A., and Pober J.S. TNF signaling in vascular endothelial cells. Exp Mol Pathol 70 3 (2001) 317-325
25. 2+ influx and endothelial permeability. Am J Physiol Lung Cell Mol Physiol 287 6 (2004) L1303-L1313
26. Griendling K.K., Sorescu D., Lassègue B., and Ushio-Fukai M. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol 20 10 (2000) 2175-2183
27. Wimalasundera R., Fexby S., Regan L., Thom S.A., and Hughes A.D. Effect of tumour necrosis factor-a and interleukin 1b on endothelium-dependent relaxation in rat mesenteric resistance arteries in vitro. Br J Pharmacol 138 (2003) 1285-1294
28. De Palma C., Meacci E., Perrotta C., Bruni P., and Clementi E. Endothelial nitric oxide synthase activation by tumor necrosis factor alpha through neutral sphingomyelinase 2, sphingosine kinase 1, and sphingosine 1 phosphate receptors: a novel pathway relevant to the pathophysiology of endothelium. Arterioscler Thromb Vasc Biol 26 1 (2006) 99-105
29. Yoshizumi M., Perrella M.A., Burnett Jr. J.C., and Lee M.E. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res 73 1 (1993) 205-209
30. 2/IP system contributes to the development of circulatory failure in a rat model of endotoxic shock. Hypertension 52 2 (2008) 330-335
31. Vila E., and Salaices M. Cytokines and vascular reactivity in resistance arteries. Am J Physiol Heart Circ Physiol 288 3 (2005) H1016-H1021
32. Gillham J.C., Myers J.E., Baker P.N., and Taggart M.J. TNF-α alters nitric oxide- and endothelium-derived hyperpolarizing factor-mediated vasodilatation in human omental arteries. Hypertens Pregnancy 27 1 (2008) 29-38
33. Brasier A.R., Recinos III A., and Eledrisi M.S. Vascular inflammation and the rennin-angiotensin system. Arterioscler Thromb Vasc Biol 22 8 (2002) 1257-1266
34. Wassmann S., Stumpf M., Strehlow K., Schmid A., Schieffer B., Böhm M., et al. Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor. Circ Res 94 4 (2004) 534-541
35. Marsden P.A., and Brenner B.M. Regulation of ET-1 gene by TNF-α. Am J Physiol 262 (1992) C854-C861
36. Yanes L.L., Romero D.G., Cucchiarelli V.E., Fortepiani L.A., Gomez-Sanchez C.E., Santacruz F., et al. Role of endothelin in mediating postmenopausal hypertension in a rat model. Am J Physiol Regul Integr Comp Physiol 288 1 (2005) R229-R233
37. Kranzhöfer R., Clinton S.K., Ishii K., Coughlin S.R., Fenton II J.W., and Libby P. Thrombin potently stimulates cytokine production in human vascular smooth muscle cells but not in mononuclear phagocytes. Circ Res 79 2 (1996) 286-294
38. Stanford S.J., Pepper J.R., Burke-Gaffney A., and Mitchell J.A. Cytokine-activated human vascular smooth muscle delays apoptosis of neutrophils: relevance of interactions between cyclo-oxygenase-2 and colony-stimulating factors. FASEB J 15 (2001) 1813-1815
39. Gerthoffer W.T. Mechanisms of vascular smooth muscle cell migration. Circ Res 100 5 (2007) 607-621
40. Barath P., Fishbein M.C., Cao J., Berenson J., Helfant R.H., and Forrester J.S. Detection and localization of tumor necrosis factor in human atheroma. Am J Cardiol 65 (1990) 297-302
41. Geng Y., Hansson G.K., and Holme E. Interferon-gamma and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells. Circ Res 71 5 (1992) 1268-1276
42. Tiwari S., Zhang Y., Heller J., Abernethy D.R., and Soldatov N.M. Atherosclerosis-related molecular alteration of the human CaV1.2 calcium channel alpha1C subunit. Proc Natl Acad Sci U S A 103 45 (2006) 17024-17029
43. Wilkinson M.F., Earle M.L., Triggle C.R., and Barnes S. Interleukin-1beta, tumor necrosis factor-alpha, and LPS enhance calcium channel current in isolated vascular smooth muscle cells of rat tail artery. FASEB J 10 7 (1996) 785-791
44. 2+ spark activation. Am J Physiol Cell Physiol 290 4 (2006) C964-C971
45. + channel opening to the interleukin-1 beta-induced inhibition of vascular smooth muscle contraction. J Vet Med Sci 61 4 (1999) 357-360
46. Orshal J.M., and Khalil R.A. Interleukin-6 impairs endothelium-dependent NO-cGMP-mediated relaxation and enhances contraction in systemic vessels of pregnant rats. Am J Physiol Regul Integr Comp Physiol 286 6 (2004) R1013-R1023
47. Haller H., Lindschau C., Quass P., Distler A., and Luft F.C. Differentiation of vascular smooth muscle cells and the regulation of protein kinase C-α. Circ Res 76 1 (1995) 21-29
48. Mong P.Y., Petrulio C., Kaufman H.L., and Wang Q. Activation of Rho kinase by TNF-alpha is required for JNK activation in human pulmonary microvascular endothelial cells. J Immunol 180 1 (2008) 550-558
49. Clements R.T., Minnear F.L., Singer H.A., Keller R.S., and Vincent P.A. RhoA and Rho-kinase dependent and independent signals mediate TGF-beta-induced pulmonary endothelial cytoskeletal reorganization and permeability. Am J Physiol Lung Cell Mol Physiol 288 2 (2005) L294-306
50. Stamatovic S.M., Dimitrijevic O.B., Keep R.F., and Andjelkovic A.V. Protein kinase Calpha-RhoA cross-talk in CCL2-induced alterations in brain endothelial permeability. J Biol Chem 281 13 (2006) 8379-8388
51. Petrache I., Crow M.T., Neuss M., and Garcia J.G. Central involvement of Rho family GTPases in TNF-alpha-mediated bovine pulmonary endothelial cell apoptosis. Biochem Biophys Res Commun 306 1 (2003) 244-249
52. Nwariaku F.E., Rothenbach P., Liu Z., Zhu X., Turnage R.H., and Terada L.S. Rho inhibition decreases TNF-induced endothelial MAPK activation and monolayer permeability. J Appl Physiol 95 5 (2003) 1889-1895
53. Nübel T., Dippold W., Kleinert H., Kaina B., and Fritz G. Lovastatin inhibits Rho-regulated expression of E-selectin by TNFalpha and attenuates tumor cell adhesion. FASEB J 18 (2004) 140-142
54. Chen X.L., Grey J.Y., Thomas S., Qiu F.H., Medford R.M., Wasserman M.A., et al. Sphingosine kinase-1 mediates TNF-alpha-induced MCP-1 gene expression in endothelial cells: upregulation by oscillatory flow. Am J Physiol Heart Circ Physiol 287 4 (2004) H1452-H1458
55. Singh R., Wang B., Shirvaikar A., Khan S., Kamat S., Schelling J.R., et al. The IL-1 receptor and Rho directly associate to drive cell activation in inflammation. J Clin Invest 103 11 (1999) 1561-1570
56. Hiroki J., Shimokawa H., Higashi M., Morikawa K., Kandabashi T., Kawamura N., et al. Inflammatory stimuli upregulate Rho-kinase in human coronary vascular smooth muscle cells. J Mol Cell Cardiol 37 2 (2004) 537-546
57. Funakoshi Y., Ichiki T., Shimokawa H., Egashira K., Takeda K., Kaibuchi K., et al. Rho-kinase mediates angiotensin II-induced monocyte chemoattractant protein-1 expression in rat vascular smooth muscle cells. Hypertension 38 (2001) 100-104
58. John G.R., Chen L., Rivieccio M.A., Melendez-Vasquez C.V., Hartley A., and Brosnan C.F. Interleukin-1beta induces a reactive astroglial phenotype via deactivation of the Rho GTPase-Rock axis. J Neurosci 24 11 (2004) 2837-2845
59. Goetze S., Xi X.P., Kawano Y., Kawano H., Fleck E., Hsueh W.A., et al. TNF-alpha-induced migration of vascular smooth muscle cells is MAPK dependent. Hypertension 33 1 Pt 2 (1999) 183-189
60. Barillari G. Inflammatory cytokines stimulate vascular smooth muscle cells locomotion and growth by enhancing α5β1 integrin expression and function. Atherosclerosis 154 (2003) 377-385
61. Amento E.P., Ehsani N., Palmer H., and Libby P. Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler Thromb 11 (1991) 1223-1230
62. Carmeliet P., Moons L., Lijnen R., Baes M., Lemaitre V., Tipping P., et al. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat Genet 17 (1997) 439-444
63. Galis Z.S., Muszynski M., Sukhova G.K., Simon-Morrissey E., Unemori E.N., Lark M.W., et al. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res 75 1 (1994) 181-189
64. Lanone S., Zheng T., Zhu Z., Liu W., Lee C.G., Ma B., et al. Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13-induced inflammation and remodeling. J Clin Invest 110 (2002) 463-474
65. Wang W., Chen H.J., Yazdani S., Simon A., Schwartz A., and Rabbani L.E. Interleukin-4 modulation of platelet-derived growth factor-induced smooth muscle cell urokinase plasminogen activator. J Thromb Thrombolysis 5 (1998) 119-123
66. Galis Z.S., Muszynski M., Sukhova G.K., Simon-Morrissey E., and Libby P. Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions. Ann N Y Acad Sci 748 (1995) 501-507
67. Tedgui A., and Mallat Z. Anti-inflammatory mechanisms in the vascular wall. Circ Res 88 9 (2001) 877-887
68. Henke P.K., DeBrunye L.A., Strieter R.M., Bromberg J.S., Prince M., Kadell A.M., et al. Viral IL-10 gene transfer decreases inflammation and cell adhesion molecule expression in a rat model of venous thrombosis. J Immunol 164 (2000) 2131-2141
69. Mallat Z., Besnard S., Duriez M., Deleuze V., Emmanuel F., Bureau M.F., et al. Protective role of interleukin-10 in atherosclerosis. Circ Res 85 (1999) e17-e24
70. Schottelius A.J., Mayo M.W., Sartor R.B., and Baldwin Jr. A.S. Interleukin-10 signaling blocks inhibitor of B kinase activity and nuclear factor B DNA binding. J Biol Chem 274 (1999) 31868-31874
71. Suttles J., Milhorn D.M., Miller R.W., Poe J.C., Wahl L.M., and Stout R.D. CD40 signaling of monocyte inflammatory cytokine synthesis through an ERK1/2-dependent pathway: a target of interleukin (IL)-4 and IL-10 anti-inflammatory action. J Biol Chem 274 (1999) 5835-5842
72. De Caterina R., Libby P., Peng H.B., Thannickal V.J., Rajavashisth T.B., Gimbrone Jr. M.A., et al. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 96 1 (1995) 60-68
73. 2+, calmodulin, and protein kinase C in H2O2-induced activation of ERK1/2, p38 MAPK, and protein kinase B signaling in vascular smooth muscle cells. Antioxid Redox Signal 6 2 (2004) 353-366
74. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342 12 (2000) 836-843
75. Shimizu K., Mitchell R.N., and Libby P. Inflammation and cellular immune responses in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 26 5 (2006) 987-994
76. Chakrabarti S., Blair P., and Freedman J.E. CD40-40L signaling in vascular inflammation. J Biol Chem 282 25 (2007) 18307-18317
77. Thompson R.W., and Parks W.C. Role of matrix metalloproteinases in abdominal aortic aneurysms. Ann N Y Acad Sci 800 (1996) 157-174
78. Fontaine V., Jacob M.P., Houard X., Rossignol P., Plissonnier D., Angles-Cano E., et al. Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms. Am J Pathol 161 (2002) 1701-1710
79. Juvonen J., Surcel H.M., Satta J., Teppo A.M., Bloigu A., Syrjala H., et al. Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 17 (1997) 2843-2847
80. Tang P.C., Yakimov A.O., Teesdale M.A., Coady M.A., Dardik A., Elefteriades J.A., et al. Transmural inflammation by interferon-gamma-producing T cells correlates with outward vascular remodeling and intimal expansion of ascending thoracic aortic aneurysms. FASEB J 19 (2005) 1528-1530
81. Dollery C.M., Owen C.A., Sukhova G.K., Krettek A., Shapiro S.D., and Libby P. Neutrophil elastase in human atherosclerotic plaques: production by macrophages. Circulation 107 22 (2003) 2829-2836
82. Miller Jr. F.J., Sharp W.J., Fang X., Oberley L.W., Oberley T.D., and Weintraub N.L. Oxidative stress in human abdominal aortic aneurysms: a potential mediator of aneurysmal remodeling. Arterioscler Thromb Vasc Biol 22 (2002) 560-565
83. Wu Z., MacPhee I.A., and Oliveira D.B. Reactive oxygen species in the initiation of IL-4 driven autoimmunity as a potential therapeutic target. Curr Pharm Des 10 (2004) 899-913
84. Satokowa H., Hoshino S., Igari T., Iwaya F., and Midorikawa H. The appearance of cytokines and adhesion molecules in saphenous vein valves in chronic venous insufficiency. Phlebology 16 (2002) 106-110
85. Takase S., Bergan J.J., and Schmid-Schönbein G. Expression of adhesion molecules and cytokines on saphenous veins in chronic venous insufficiency. Ann Vasc Surg 14 5 (2000) 427-435
86. Chae C.U., Lee R.T., Rifai N., and Ridker P.M. Blood pressure and inflammation in apparently healthy men. Hypertension 38 3 (2001) 399-403
87. Ruiz-Ortega M., Ruperez M., Lorenzo O., Esteban V., Blanco J., Mezzano S., et al. Angiotensin II regulates the synthesis of proinflammatory cytokines and chemokines in the kidney. Kidney Int Suppl 82 (2002) 12-22
88. Lee D.L., Sturgis L.C., Labazi H., Osborne Jr. J.B., Fleming C., Pollock J.S., et al. Angiotensin II hypertension is attenuated in interleukin-6 knockout mice. Am J Physiol Heart Circ Physiol 290 3 (2006) H935-H940
89. Lijnen P.J., Petrov V.V., and Fagard R.H. Association between transforming growth factor-beta and hypertension. Am J Hypertens 16 7 (2003) 604-611
90. Gilbert J.S., Ryan M.J., LaMarca B.B., Sedeek M., Murphy S.R., and Granger J.P. Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am J Physiol Heart Circ Physiol 294 2 (2008) H541-H550
91. Conrad K.P., Miles T.M., and Benyo D.F. Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol 40 (1998) 102-111
92. Gareus R., Kotsaki E., Xanthoulea S., van der Made I., Gijbels M.J., Kardakaris R., et al. Endothelial cell-specific NF-kappaB inhibition protects mice from atherosclerosis. Cell Metab 8 5 (2008) 372-383
93. Pozo M., Izquierdo M.C., de Nicolás R., Egido J., Ortiz A., and González-Cabrero J. Gliotoxin inhibits neointimal hyperplasia after vascular injury in rats. J Vasc Res 46 4 (2008) 278-289
94. Tham D.M., Wang Y.X., and Rutledge J.C. Modulation of vascular inflammation by PPARs. Drug News Perspect 16 2 (2003) 109-116
95. Lutgens E., and Daemen M.J. CD40-CD40L interactions in atherosclerosis. Trends Cardiovasc Med 12 1 (2002) 27-32
96. Nakano K., Egashira K., Tada H., Kohjimoto Y., Hirouchi Y., Kitajima S., et al. A third-generation, long-acting, dihydropyridine calcium antagonist, azelnidipine, attenuates stent-associated neointimal formation in non-human primates. J Hypertens 24 9 (2006) 1881-1889
97. Yoshii T., Iwai M., Li Z., Chen R., Ide A., Fukunaga S., et al. Regression of atherosclerosis by amlodipine via anti-inflammatory and anti-oxidative stress actions. Hypertens Res 29 6 (2006) 457-466
98. Matsumoto Y., Uwatoku T., Oi K., Abe K., Hattori T., Morishige K., et al. Long-term inhibition of Rho-kinase suppresses neointimal formation after stent implantation in porcine coronary arteries: involvement of multiple mechanisms. Arterioscler Thromb Vasc Biol 24 1 (2004) 181-186
99. Rey F.E., Cifuentes M.E., Kiarash A., Quinn M.T., and Pagano P.J. Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O(2)(-) and systolic blood pressure in mice. Circ Res 89 5 (2001) 408-414
100. Channon K.M., Qian H.S., and George S.E. Nitric oxide synthase in atherosclerosis and vascular injury: insights from experimental gene therapy. Arteriosc Thromb Vasc Biol 20 (2000) 1873-1881